nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxorubicin—liver cancer—gallbladder cancer	0.371	0.415	CtDrD
Doxorubicin—stomach cancer—gallbladder cancer	0.27	0.302	CtDrD
Doxorubicin—pancreatic cancer—gallbladder cancer	0.252	0.282	CtDrD
Doxorubicin—ABCB11—bile duct—gallbladder cancer	0.00941	0.136	CbGeAlD
Doxorubicin—ABCB11—bile—gallbladder cancer	0.00723	0.104	CbGeAlD
Doxorubicin—ABCC3—bile duct—gallbladder cancer	0.00599	0.0864	CbGeAlD
Doxorubicin—ABCC2—bile duct—gallbladder cancer	0.00478	0.069	CbGeAlD
Doxorubicin—NOS1—Quercetin and Nf-kB/ AP-1 Induced Cell Apoptosis—KEAP1—gallbladder cancer	0.0043	0.113	CbGpPWpGaD
Doxorubicin—ABCC2—bile—gallbladder cancer	0.00368	0.053	CbGeAlD
Doxorubicin—CBR3—NRF2 pathway—KEAP1—gallbladder cancer	0.00327	0.0856	CbGpPWpGaD
Doxorubicin—NQO1—Transcriptional activation by NRF2—KEAP1—gallbladder cancer	0.00325	0.0851	CbGpPWpGaD
Doxorubicin—AKR1A1—pancreas—gallbladder cancer	0.0015	0.0216	CbGeAlD
Doxorubicin—NQO1—gall bladder—gallbladder cancer	0.00142	0.0205	CbGeAlD
Doxorubicin—RALBP1—RalA downstream regulated genes—NRAS—gallbladder cancer	0.00133	0.0347	CbGpPWpGaD
Doxorubicin—ABCB8—liver—gallbladder cancer	0.00128	0.0185	CbGeAlD
Doxorubicin—ABCC3—gall bladder—gallbladder cancer	0.00128	0.0184	CbGeAlD
Doxorubicin—NOS1—epithelium—gallbladder cancer	0.00127	0.0184	CbGeAlD
Doxorubicin—RALBP1—RalA downstream regulated genes—KRAS—gallbladder cancer	0.00114	0.0299	CbGpPWpGaD
Doxorubicin—NDUFS2—pancreas—gallbladder cancer	0.00113	0.0163	CbGeAlD
Doxorubicin—NDUFS3—pancreas—gallbladder cancer	0.00111	0.0161	CbGeAlD
Doxorubicin—DHCR7—pancreas—gallbladder cancer	0.00106	0.0153	CbGeAlD
Doxorubicin—ABCB8—lymph node—gallbladder cancer	0.000982	0.0142	CbGeAlD
Doxorubicin—YWHAG—pancreas—gallbladder cancer	0.000971	0.014	CbGeAlD
Doxorubicin—RALBP1—RalA downstream regulated genes—HRAS—gallbladder cancer	0.00097	0.0254	CbGpPWpGaD
Doxorubicin—NOS3—epithelium—gallbladder cancer	0.000968	0.014	CbGeAlD
Doxorubicin—AKR1A1—liver—gallbladder cancer	0.000952	0.0137	CbGeAlD
Doxorubicin—CBR3—lymph node—gallbladder cancer	0.000946	0.0136	CbGeAlD
Doxorubicin—CBR1—NRF2 pathway—KEAP1—gallbladder cancer	0.000902	0.0236	CbGpPWpGaD
Doxorubicin—YWHAG—Activation of BAD and translocation to mitochondria—BCL2—gallbladder cancer	0.000885	0.0232	CbGpPWpGaD
Doxorubicin—RALBP1—pancreas—gallbladder cancer	0.000877	0.0126	CbGeAlD
Doxorubicin—NDUFS7—liver—gallbladder cancer	0.000865	0.0125	CbGeAlD
Doxorubicin—AKR1C3—pancreas—gallbladder cancer	0.000808	0.0117	CbGeAlD
Doxorubicin—AURKA—liver—gallbladder cancer	0.000805	0.0116	CbGeAlD
Doxorubicin—NQO1—epithelium—gallbladder cancer	0.000736	0.0106	CbGeAlD
Doxorubicin—AKR1A1—lymph node—gallbladder cancer	0.00073	0.0105	CbGeAlD
Doxorubicin—NDUFS2—liver—gallbladder cancer	0.000717	0.0103	CbGeAlD
Doxorubicin—NDUFS3—liver—gallbladder cancer	0.000708	0.0102	CbGeAlD
Doxorubicin—DHCR7—liver—gallbladder cancer	0.000673	0.00971	CbGeAlD
Doxorubicin—NDUFS7—lymph node—gallbladder cancer	0.000664	0.00958	CbGeAlD
Doxorubicin—ABCC6—liver—gallbladder cancer	0.000656	0.00946	CbGeAlD
Doxorubicin—NQO1—pancreas—gallbladder cancer	0.000656	0.00946	CbGeAlD
Doxorubicin—YWHAG—liver—gallbladder cancer	0.000618	0.00891	CbGeAlD
Doxorubicin—AURKA—lymph node—gallbladder cancer	0.000617	0.0089	CbGeAlD
Doxorubicin—XDH—liver—gallbladder cancer	0.000602	0.00869	CbGeAlD
Doxorubicin—ABCB11—liver—gallbladder cancer	0.000588	0.00849	CbGeAlD
Doxorubicin—YWHAG—Activation of BH3-only proteins—BCL2—gallbladder cancer	0.000588	0.0154	CbGpPWpGaD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—BCL2—gallbladder cancer	0.00057	0.0149	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—ERBB3—gallbladder cancer	0.000569	0.0149	CbGpPWpGaD
Doxorubicin—RALBP1—liver—gallbladder cancer	0.000558	0.00805	CbGeAlD
Doxorubicin—NDUFS2—lymph node—gallbladder cancer	0.00055	0.00793	CbGeAlD
Doxorubicin—NOS3—liver—gallbladder cancer	0.000549	0.00792	CbGeAlD
Doxorubicin—NDUFS3—lymph node—gallbladder cancer	0.000543	0.00784	CbGeAlD
Doxorubicin—NQO1—NRF2 pathway—KEAP1—gallbladder cancer	0.000527	0.0138	CbGpPWpGaD
Doxorubicin—CBR1—liver—gallbladder cancer	0.000521	0.00751	CbGeAlD
Doxorubicin—DHCR7—lymph node—gallbladder cancer	0.000516	0.00745	CbGeAlD
Doxorubicin—AKR1C3—liver—gallbladder cancer	0.000514	0.00742	CbGeAlD
Doxorubicin—NQO1—Apoptosis-related network due to altered Notch3 in ovarian cancer—ERBB3—gallbladder cancer	0.000487	0.0127	CbGpPWpGaD
Doxorubicin—YWHAG—lymph node—gallbladder cancer	0.000473	0.00683	CbGeAlD
Doxorubicin—POR—liver—gallbladder cancer	0.00047	0.00678	CbGeAlD
Doxorubicin—RALBP1—lymph node—gallbladder cancer	0.000428	0.00617	CbGeAlD
Doxorubicin—NOS3—lymph node—gallbladder cancer	0.000421	0.00607	CbGeAlD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—BCL2—gallbladder cancer	0.000421	0.011	CbGpPWpGaD
Doxorubicin—NQO1—liver—gallbladder cancer	0.000417	0.00602	CbGeAlD
Doxorubicin—CBR1—lymph node—gallbladder cancer	0.000399	0.00576	CbGeAlD
Doxorubicin—AKR1C3—lymph node—gallbladder cancer	0.000394	0.00569	CbGeAlD
Doxorubicin—ABCC3—liver—gallbladder cancer	0.000374	0.0054	CbGeAlD
Doxorubicin—ABCC10—liver—gallbladder cancer	0.000373	0.00538	CbGeAlD
Doxorubicin—AURKA—Aurora A signaling—TP53—gallbladder cancer	0.000369	0.00967	CbGpPWpGaD
Doxorubicin—POR—lymph node—gallbladder cancer	0.00036	0.00519	CbGeAlD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—ERBB2—gallbladder cancer	0.000357	0.00934	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—gallbladder cancer	0.000352	0.00922	CbGpPWpGaD
Doxorubicin—TOP2A—lymph node—gallbladder cancer	0.000336	0.00484	CbGeAlD
Doxorubicin—ABCC3—NRF2 pathway—KEAP1—gallbladder cancer	0.000334	0.00874	CbGpPWpGaD
Doxorubicin—YWHAG—Activation of BH3-only proteins—TP53—gallbladder cancer	0.000332	0.0087	CbGpPWpGaD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—NRAS—gallbladder cancer	0.000325	0.0085	CbGpPWpGaD
Doxorubicin—NOS1—Amyotrophic lateral sclerosis (ALS)—TP53—gallbladder cancer	0.000323	0.00844	CbGpPWpGaD
Doxorubicin—NQO1—lymph node—gallbladder cancer	0.00032	0.00462	CbGeAlD
Doxorubicin—YWHAG—Role of Calcineurin-dependent NFAT signaling in lymphocytes—BCL2—gallbladder cancer	0.000317	0.00831	CbGpPWpGaD
Doxorubicin—NOS2—ATF-2 transcription factor network—BCL2—gallbladder cancer	0.000303	0.00792	CbGpPWpGaD
Doxorubicin—ABCC2—liver—gallbladder cancer	0.000299	0.00432	CbGeAlD
Doxorubicin—CYP1B1—liver—gallbladder cancer	0.000293	0.00423	CbGeAlD
Doxorubicin—ABCC3—lymph node—gallbladder cancer	0.000287	0.00414	CbGeAlD
Doxorubicin—ABCC10—lymph node—gallbladder cancer	0.000286	0.00412	CbGeAlD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—KRAS—gallbladder cancer	0.000279	0.00731	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—NRAS—gallbladder cancer	0.000268	0.00701	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—ERBB2—gallbladder cancer	0.000266	0.00695	CbGpPWpGaD
Doxorubicin—ABCC2—NRF2 pathway—KEAP1—gallbladder cancer	0.000265	0.00693	CbGpPWpGaD
Doxorubicin—ABCC1—liver—gallbladder cancer	0.000264	0.0038	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.00026	0.00681	CbGpPWpGaD
Doxorubicin—NOS2—Signaling mediated by p38-alpha and p38-beta—TP53—gallbladder cancer	0.00026	0.0068	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—EGFR—gallbladder cancer	0.000247	0.00648	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—EGFR—gallbladder cancer	0.000244	0.00639	CbGpPWpGaD
Doxorubicin—YWHAG—Intrinsic Pathway for Apoptosis—TP53—gallbladder cancer	0.000238	0.00622	CbGpPWpGaD
Doxorubicin—YWHAG—Trk receptor signaling mediated by PI3K and PLC-gamma—HRAS—gallbladder cancer	0.000237	0.00622	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000237	0.0062	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000237	0.0062	CbGpPWpGaD
Doxorubicin—TOP2A—Gastric Cancer Network 2—EGFR—gallbladder cancer	0.000233	0.0061	CbGpPWpGaD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—NRAS—gallbladder cancer	0.000232	0.00608	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—KRAS—gallbladder cancer	0.000231	0.00603	CbGpPWpGaD
Doxorubicin—ABCC2—lymph node—gallbladder cancer	0.000229	0.00331	CbGeAlD
Doxorubicin—CYP1B1—lymph node—gallbladder cancer	0.000225	0.00324	CbGeAlD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000224	0.00586	CbGpPWpGaD
Doxorubicin—ABCG2—liver—gallbladder cancer	0.000218	0.00315	CbGeAlD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.000217	0.00569	CbGpPWpGaD
Doxorubicin—YWHAG—LKB1 signaling events—TP53—gallbladder cancer	0.000215	0.00564	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—TP53—gallbladder cancer	0.000205	0.00536	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—NRAS—gallbladder cancer	0.000202	0.00529	CbGpPWpGaD
Doxorubicin—ABCC1—lymph node—gallbladder cancer	0.000202	0.00292	CbGeAlD
Doxorubicin—CYP2B6—liver—gallbladder cancer	0.000201	0.0029	CbGeAlD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—KRAS—gallbladder cancer	0.0002	0.00524	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—NRAS—gallbladder cancer	0.0002	0.00523	CbGpPWpGaD
Doxorubicin—YWHAG—a6b1 and a6b4 Integrin signaling—HRAS—gallbladder cancer	0.000199	0.0052	CbGpPWpGaD
Doxorubicin—NOS1—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	0.000196	0.00513	CbGpPWpGaD
Doxorubicin—TOP2A—Gastric Cancer Network 2—TP53—gallbladder cancer	0.000196	0.00512	CbGpPWpGaD
Doxorubicin—NQO1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	0.00019	0.00498	CbGpPWpGaD
Doxorubicin—ABCB1—epithelium—gallbladder cancer	0.00019	0.00274	CbGeAlD
Doxorubicin—NOS3—Leptin signaling pathway—ERBB2—gallbladder cancer	0.000188	0.00493	CbGpPWpGaD
Doxorubicin—NOS2—AGE/RAGE pathway—EGFR—gallbladder cancer	0.000186	0.00488	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—EGFR—gallbladder cancer	0.000184	0.00482	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—BCL2—gallbladder cancer	0.000184	0.00482	CbGpPWpGaD
Doxorubicin—NOS1—Alzheimers Disease—TP53—gallbladder cancer	0.00018	0.0047	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—NRAS—gallbladder cancer	0.000176	0.00461	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—KRAS—gallbladder cancer	0.000174	0.00455	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—KRAS—gallbladder cancer	0.000172	0.0045	CbGpPWpGaD
Doxorubicin—NOS3—Plasma membrane estrogen receptor signaling—HRAS—gallbladder cancer	0.00017	0.00445	CbGpPWpGaD
Doxorubicin—ABCB1—pancreas—gallbladder cancer	0.000169	0.00244	CbGeAlD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.000169	0.00442	CbGpPWpGaD
Doxorubicin—ABCG2—lymph node—gallbladder cancer	0.000167	0.00241	CbGeAlD
Doxorubicin—NOS3—Thromboxane A2 receptor signaling—EGFR—gallbladder cancer	0.000165	0.00432	CbGpPWpGaD
Doxorubicin—NOS3—Corticotropin-releasing hormone—BCL2—gallbladder cancer	0.000165	0.00431	CbGpPWpGaD
Doxorubicin—ABCC3—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.000164	0.0043	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—EGFR—gallbladder cancer	0.00016	0.0042	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—EGFR—gallbladder cancer	0.000155	0.00406	CbGpPWpGaD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—TP53—gallbladder cancer	0.000155	0.00405	CbGpPWpGaD
Doxorubicin—CYP3A4—liver—gallbladder cancer	0.000152	0.00219	CbGeAlD
Doxorubicin—NOS3—SHP2 signaling—KRAS—gallbladder cancer	0.000152	0.00397	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.000151	0.00394	CbGpPWpGaD
Doxorubicin—CYP2D6—liver—gallbladder cancer	0.00015	0.00216	CbGeAlD
Doxorubicin—NOS2—Rac1/Pak1/p38/MMP-2 pathway—HRAS—gallbladder cancer	0.000148	0.00387	CbGpPWpGaD
Doxorubicin—YWHAG—mTOR signaling pathway—HRAS—gallbladder cancer	0.000146	0.00383	CbGpPWpGaD
Doxorubicin—NOS3—AGE/RAGE pathway—EGFR—gallbladder cancer	0.000145	0.00379	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000142	0.00372	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—NRAS—gallbladder cancer	0.000138	0.00361	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—BCL2—gallbladder cancer	0.000137	0.00358	CbGpPWpGaD
Doxorubicin—NOS1—Spinal Cord Injury—TP53—gallbladder cancer	0.00013	0.00341	CbGpPWpGaD
Doxorubicin—NOS3—SHP2 signaling—HRAS—gallbladder cancer	0.000129	0.00337	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—EGFR—gallbladder cancer	0.000126	0.00329	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—NRAS—gallbladder cancer	0.000125	0.00327	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—EGFR—gallbladder cancer	0.000124	0.00324	CbGpPWpGaD
Doxorubicin—RALBP1—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	0.000121	0.00317	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—NRAS—gallbladder cancer	0.00012	0.00314	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—KRAS—gallbladder cancer	0.000119	0.00311	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	0.000117	0.00307	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—KRAS—gallbladder cancer	0.000117	0.00306	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—EGFR—gallbladder cancer	0.000117	0.00306	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor Pathway—EGFR—gallbladder cancer	0.000114	0.00298	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—EGFR—gallbladder cancer	0.000114	0.00298	CbGpPWpGaD
Doxorubicin—ABCG2—Fluoropyrimidine Activity—TP53—gallbladder cancer	0.000113	0.00297	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	0.000111	0.0029	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—gallbladder cancer	0.000108	0.00283	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—NRAS—gallbladder cancer	0.000108	0.00282	CbGpPWpGaD
Doxorubicin—ABCB1—liver—gallbladder cancer	0.000108	0.00155	CbGeAlD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—KRAS—gallbladder cancer	0.000108	0.00281	CbGpPWpGaD
Doxorubicin—NOS3—Leptin signaling pathway—HRAS—gallbladder cancer	0.000105	0.00274	CbGpPWpGaD
Doxorubicin—AURKA—Integrated Breast Cancer Pathway—TP53—gallbladder cancer	0.000104	0.00272	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—KRAS—gallbladder cancer	0.000103	0.0027	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—NRAS—gallbladder cancer	0.000102	0.00267	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—ERBB2—gallbladder cancer	0.000102	0.00266	CbGpPWpGaD
Doxorubicin—YWHAG—ErbB1 downstream signaling—HRAS—gallbladder cancer	0.000101	0.00264	CbGpPWpGaD
Doxorubicin—NOS2—Spinal Cord Injury—TP53—gallbladder cancer	9.83e-05	0.00257	CbGpPWpGaD
Doxorubicin—AURKA—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	9.41e-05	0.00246	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—KRAS—gallbladder cancer	9.28e-05	0.00243	CbGpPWpGaD
Doxorubicin—CYP1B1—Aryl Hydrocarbon Receptor—HRAS—gallbladder cancer	9.14e-05	0.00239	CbGpPWpGaD
Doxorubicin—YWHAG—PDGFR-beta signaling pathway—HRAS—gallbladder cancer	8.77e-05	0.0023	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—KRAS—gallbladder cancer	8.76e-05	0.00229	CbGpPWpGaD
Doxorubicin—TOP2A—Retinoblastoma (RB) in Cancer—TP53—gallbladder cancer	8.57e-05	0.00224	CbGpPWpGaD
Doxorubicin—ABCB1—lymph node—gallbladder cancer	8.25e-05	0.00119	CbGeAlD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	8.08e-05	0.00212	CbGpPWpGaD
Doxorubicin—NOS3—VEGFA-VEGFR2 Pathway—HRAS—gallbladder cancer	7.89e-05	0.00207	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	7.85e-05	0.00206	CbGpPWpGaD
Doxorubicin—YWHAG—Apoptosis—TP53—gallbladder cancer	7.72e-05	0.00202	CbGpPWpGaD
Doxorubicin—NOS3—Signaling by VEGF—HRAS—gallbladder cancer	7.45e-05	0.00195	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—EGFR—gallbladder cancer	7.05e-05	0.00185	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—KRAS—gallbladder cancer	6.66e-05	0.00174	CbGpPWpGaD
Doxorubicin—NOS2—Circadian rythm related genes—TP53—gallbladder cancer	6.42e-05	0.00168	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ERBB4—gallbladder cancer	6.24e-05	0.00163	CbGpPWpGaD
Doxorubicin—NOS3—EGF/EGFR Signaling Pathway—HRAS—gallbladder cancer	5.66e-05	0.00148	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ERBB4—gallbladder cancer	5.46e-05	0.00143	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	5.44e-05	0.00142	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ERBB3—gallbladder cancer	5.39e-05	0.00141	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—NRAS—gallbladder cancer	5.31e-05	0.00139	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	5.14e-05	0.00135	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ERBB3—gallbladder cancer	4.72e-05	0.00124	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ERBB4—gallbladder cancer	4.71e-05	0.00123	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—KRAS—gallbladder cancer	4.57e-05	0.0012	CbGpPWpGaD
Doxorubicin—TOP2A—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	4.57e-05	0.0012	CbGpPWpGaD
Doxorubicin—TOP2A—Circadian rythm related genes—TP53—gallbladder cancer	4.39e-05	0.00115	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB4—gallbladder cancer	4.32e-05	0.00113	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ERBB3—gallbladder cancer	4.07e-05	0.00106	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—TP53—gallbladder cancer	4.07e-05	0.00106	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—NRAS—gallbladder cancer	4.01e-05	0.00105	CbGpPWpGaD
Doxorubicin—NOS1—Hemostasis—HRAS—gallbladder cancer	3.89e-05	0.00102	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB3—gallbladder cancer	3.74e-05	0.000979	CbGpPWpGaD
Doxorubicin—AURKA—Cell Cycle—TP53—gallbladder cancer	3.73e-05	0.000977	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB4—gallbladder cancer	3.65e-05	0.000956	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—KRAS—gallbladder cancer	3.45e-05	0.000903	CbGpPWpGaD
Doxorubicin—NOS1—Disease—ERBB2—gallbladder cancer	3.38e-05	0.000885	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB3—gallbladder cancer	3.16e-05	0.000827	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—NRAS—gallbladder cancer	3.11e-05	0.000815	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—TP53—gallbladder cancer	3.07e-05	0.000803	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB4—gallbladder cancer	3.03e-05	0.000793	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—ERBB2—gallbladder cancer	2.96e-05	0.000775	CbGpPWpGaD
Doxorubicin—NOS2—Hemostasis—HRAS—gallbladder cancer	2.93e-05	0.000768	CbGpPWpGaD
Doxorubicin—YWHAG—Cell Cycle—TP53—gallbladder cancer	2.83e-05	0.00074	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—KRAS—gallbladder cancer	2.68e-05	0.000701	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—BCL2—gallbladder cancer	2.66e-05	0.000697	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB3—gallbladder cancer	2.62e-05	0.000685	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—gallbladder cancer	2.59e-05	0.000677	CbGpPWpGaD
Doxorubicin—NOS1—Disease—NRAS—gallbladder cancer	2.57e-05	0.000673	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB4—gallbladder cancer	2.56e-05	0.00067	CbGpPWpGaD
Doxorubicin—NOS2—Disease—ERBB2—gallbladder cancer	2.55e-05	0.000668	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—TP53—gallbladder cancer	2.38e-05	0.000623	CbGpPWpGaD
Doxorubicin—NOS1—Disease—EGFR—gallbladder cancer	2.34e-05	0.000614	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—ERBB2—gallbladder cancer	2.34e-05	0.000614	CbGpPWpGaD
Doxorubicin—NOS3—Hemostasis—HRAS—gallbladder cancer	2.28e-05	0.000596	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—NRAS—gallbladder cancer	2.25e-05	0.00059	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB4—gallbladder cancer	2.23e-05	0.000583	CbGpPWpGaD
Doxorubicin—NOS1—Disease—KRAS—gallbladder cancer	2.21e-05	0.00058	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB3—gallbladder cancer	2.21e-05	0.000579	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—EGFR—gallbladder cancer	2.05e-05	0.000537	CbGpPWpGaD
Doxorubicin—NOS3—Disease—ERBB2—gallbladder cancer	1.98e-05	0.000518	CbGpPWpGaD
Doxorubicin—TOP2A—Cell Cycle—TP53—gallbladder cancer	1.98e-05	0.000518	CbGpPWpGaD
Doxorubicin—NOS2—Disease—NRAS—gallbladder cancer	1.94e-05	0.000508	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—KRAS—gallbladder cancer	1.94e-05	0.000508	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB3—gallbladder cancer	1.92e-05	0.000504	CbGpPWpGaD
Doxorubicin—NOS1—Disease—HRAS—gallbladder cancer	1.88e-05	0.000493	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—gallbladder cancer	1.79e-05	0.000469	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—NRAS—gallbladder cancer	1.78e-05	0.000467	CbGpPWpGaD
Doxorubicin—NOS2—Disease—EGFR—gallbladder cancer	1.77e-05	0.000463	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—TP53—gallbladder cancer	1.72e-05	0.000451	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—gallbladder cancer	1.69e-05	0.000443	CbGpPWpGaD
Doxorubicin—NOS2—Disease—KRAS—gallbladder cancer	1.67e-05	0.000437	CbGpPWpGaD
Doxorubicin—RALBP1—Signaling Pathways—HRAS—gallbladder cancer	1.65e-05	0.000432	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—ERBB2—gallbladder cancer	1.64e-05	0.00043	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—EGFR—gallbladder cancer	1.62e-05	0.000425	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—KRAS—gallbladder cancer	1.53e-05	0.000402	CbGpPWpGaD
Doxorubicin—NOS3—Disease—NRAS—gallbladder cancer	1.51e-05	0.000394	CbGpPWpGaD
Doxorubicin—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—gallbladder cancer	1.5e-05	0.000394	CbGpPWpGaD
Doxorubicin—NOS2—Disease—HRAS—gallbladder cancer	1.42e-05	0.000372	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—ERBB2—gallbladder cancer	1.39e-05	0.000363	CbGpPWpGaD
Doxorubicin—NOS3—Disease—EGFR—gallbladder cancer	1.37e-05	0.000359	CbGpPWpGaD
Doxorubicin—AKR1C3—Disease—HRAS—gallbladder cancer	1.3e-05	0.000342	CbGpPWpGaD
Doxorubicin—NOS3—Disease—KRAS—gallbladder cancer	1.3e-05	0.000339	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—NRAS—gallbladder cancer	1.25e-05	0.000327	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—ERBB2—gallbladder cancer	1.21e-05	0.000316	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—EGFR—gallbladder cancer	1.14e-05	0.000298	CbGpPWpGaD
Doxorubicin—NOS3—Disease—HRAS—gallbladder cancer	1.1e-05	0.000289	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—KRAS—gallbladder cancer	1.07e-05	0.000281	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—NRAS—gallbladder cancer	1.06e-05	0.000276	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—EGFR—gallbladder cancer	9.61e-06	0.000252	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—TP53—gallbladder cancer	9.55e-06	0.00025	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—NRAS—gallbladder cancer	9.18e-06	0.00024	CbGpPWpGaD
Doxorubicin—AKR1C3—Signaling Pathways—HRAS—gallbladder cancer	9.14e-06	0.000239	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—KRAS—gallbladder cancer	9.08e-06	0.000238	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—EGFR—gallbladder cancer	8.37e-06	0.000219	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—TP53—gallbladder cancer	8.07e-06	0.000211	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—KRAS—gallbladder cancer	7.9e-06	0.000207	CbGpPWpGaD
Doxorubicin—NOS3—Signaling Pathways—HRAS—gallbladder cancer	7.72e-06	0.000202	CbGpPWpGaD
Doxorubicin—ABCC1—Disease—HRAS—gallbladder cancer	6.72e-06	0.000176	CbGpPWpGaD
